Revance Therapeutics Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2020
Net Income	-553	106	-9,747	323	325	2,236	Upgrade
Depreciation & Amortization	148	161	182	171	196	221	Upgrade
Other Amortization	40	40	118	97	102	93	Upgrade
Asset Writedown & Restructuring Costs	-	-	1	2	28	888	Upgrade
Loss (Gain) on Equity Investments	101	101	100	300	500	1,200	Upgrade
Other Operating Activities	-260	-1,327	7,904	-589	183	-1,795	Upgrade
Change in Accounts Receivable	-119	-119	55	-322	-48	-	Upgrade
Change in Inventory	640	640	-161	-1,663	-930	-	Upgrade
Change in Other Net Operating Assets	-963	-1,601	-1,800	-1,320	161	-674	Upgrade
Operating Cash Flow	-966	-1,999	-3,348	-3,001	477	1,526	Upgrade
Operating Cash Flow Growth	-	-	-	-	-68.74%	153.49%	Upgrade
Capital Expenditures	-40	-43	-159	-186	-216	-147	Upgrade
Cash Acquisitions	-	-	-	-387	-	-	Upgrade
Divestitures	6	132	5	-	443	-222	Upgrade
Other Investing Activities	19	16	17	71	16	2	Upgrade
Investing Cash Flow	-15	105	-137	-502	243	-367	Upgrade
Long-Term Debt Issued	-	-	4,985	1,400	-	1,500	Upgrade
Total Debt Issued	-	-	4,985	1,400	-	1,500	Upgrade
Short-Term Debt Repaid	-	-	-	-	-	-1,720	Upgrade
Long-Term Debt Repaid	-	-3,252	-1,717	-872	-1,343	-135	Upgrade
Total Debt Repaid	-56	-3,252	-1,717	-872	-1,343	-1,855	Upgrade
Net Debt Issued (Repaid)	-56	-3,252	3,268	528	-1,343	-355	Upgrade
Issuance of Common Stock	-	4,000	-	-	4,292	-	Upgrade
Other Financing Activities	-3	-396	21	7	-39	54	Upgrade
Financing Cash Flow	-78	352	3,289	535	2,910	-301	Upgrade
Foreign Exchange Rate Adjustments	-10	13	-10	41	32	-56	Upgrade
Net Cash Flow	-1,069	-1,529	-206	-2,927	3,662	802	Upgrade
Free Cash Flow	-1,006	-2,042	-3,507	-3,187	261	1,379	Upgrade
Free Cash Flow Growth	-	-	-	-	-81.07%	223.71%	Upgrade
Free Cash Flow Margin	-5.61%	-11.04%	-18.89%	-20.31%	2.06%	11.49%	Upgrade
Free Cash Flow Per Share	-0.22	-0.50	-44.83	-40.74	3.39	20.38	Upgrade
Cash Interest Paid	245	245	222	132	77	62	Upgrade
Cash Income Tax Paid	45	45	67	274	111	157	Upgrade
Levered Free Cash Flow	-301.13	-298	2,438	-3,720	1.88	178.88	Upgrade
Unlevered Free Cash Flow	677	-60.5	2,637	-3,634	73.75	228.88	Upgrade
Change in Net Working Capital	-547	48	-3,228	3,523	451	546	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.